Can Turmeric, Green Tea Extract, or Ashwagandha Damage Your Liver?

Can turmeric, green tea extract, or ashwagandha damage your liver?

You bought it to get healthier. That is the paradox sitting at the center of this, and it is why the conversation is such a hard one to have. Turmeric for inflammation, green tea extract for weight, ashwagandha for stress. Chosen deliberately, taken faithfully, and every so often the reason someone ends up in a hepatology clinic. In two decades of practicing medicine I have watched that aisle grow from a few bottles into a wall, and I have watched the liver-injury literature grow right alongside it. Herbal and dietary supplements are now the second most common cause of idiosyncratic drug-induced liver injury in the United States, behind antibiotics, and the single most frequently implicated category in the national registry that tracks these cases, rising from roughly seven to nine percent of cases in the mid-2000s to about twenty percent a decade later. I am a naturopathic physician. I use botanicals. That is exactly why I want you to hear this from me instead of from a hospital admitting note.

The four that show up most

Green tea extract. The prototype. The suspected culprit is the catechin EGCG, concentrated far beyond anything you would drink. The injury is hepatocellular in roughly ninety-five percent of cases, shows up most often one to three months in, and most patients are visibly ill and jaundiced by the time they present. In the national cohort it accounted for about three percent of all drug-induced liver injury, ran a severe course in about a third, and led to transplant in roughly one in twelve.
Turmeric and curcumin. The fastest riser. Reports climbed sharply after 2017, tracking the shift to concentrated, high-absorption formulas. Same picture as green tea: hepatocellular, one to four months in, jaundice and malaise, and sometimes caught only because someone ran routine labs. In the ten-case federal series there was one death.
Garcinia cambogia. A weight-loss ingredient. Hepatocellular injury inside one to four months. A pooled analysis of thirty-four reports counted nine transplants and one death from liver failure.
Ashwagandha. The odd one out, and the one I am asked about most because it is everywhere now for stress and sleep. It injures bile flow rather than liver cells, so it shows up as jaundice and relentless itching, and it moves faster, often two to twelve weeks. Controlled trials at ordinary doses over eight to twelve weeks, and a systematic review of thirty trials, did not turn up serious liver events, so this is not a common outcome. But the case series are real, several were confirmed to be unadulterated product, and at least one patient needed a transplant.

Beyond those four: anabolic steroids sold as bodybuilding supplements, multi-ingredient weight-loss and bodybuilding blends, which are still the majority of cases and where the responsible ingredient usually cannot be identified at all, and the older botanicals including chaparral, ephedra, germander, He Shou Wu, and kratom.

The spice is not the problem. The capsule is.

This distinction matters and it gets lost constantly. Turmeric as a culinary spice is not implicated in any of this. Traditionally brewed green tea, a few cups a day, is considered safe, and the European food-safety review that flagged concentrated catechins said so explicitly. What changed is the delivery. Manufacturers added black pepper extract, which blocks the enzymes and transport pumps that normally clear curcumin, plus coatings and emulsifiers that push absorption higher still. The products that appear in case reports are disproportionately these high-absorption formulas. We engineered a spice into a drug and kept selling it as a spice.

Two other things stack the deck. Taking these on an empty stomach raises catechin absorption several-fold. And supplements are not tested the way a prescription is, so mislabeling and adulteration are common, and what is inside a bottle can change while the brand name on the front stays the same.

Why this is not really about the dose

For turmeric and green tea the injury is idiosyncratic and immune-mediated, not a straightforward case of taking too much. The evidence for that is genetic. A tissue-type variant called HLA-B*35:01 is carried by about seventy-two percent of green tea cases and seven of ten turmeric cases, against roughly five to fifteen percent of the general population. The same variant turns up across chemically unrelated botanicals, which tells you the immune system is reacting to a class of exposure rather than to one molecule.

Now the honest limits, because this is where it would be easy to oversell a test. That variant is common and this injury is rare, so most carriers who take turmeric will never have a problem, and the national guidance is explicit that it is not a screening test to run before starting a supplement. Where it earns its place is after the fact, when someone already has unexplained liver injury and we are working out the cause. A negative result there is genuinely informative and sends us looking elsewhere. A positive result adds weight, not proof. And it takes too long to come back to change what you do in the moment, which is stop the product.

The mistake this injury causes

Here is the second paradox, and clinically it is the one that concerns me more. Turmeric and green tea injury can look exactly like autoimmune hepatitis. The same antibodies turn up on the blood work, and under the microscope a biopsy can be nearly indistinguishable. The phenomenon has a name, drug-induced autoimmune-like hepatitis, and the resemblance is close enough that it gets mistaken for the real disease.

Getting that distinction wrong is not a small error. True autoimmune hepatitis is a chronic condition that generally requires long-term immunosuppression and tends to flare again when steroids are withdrawn. The supplement-triggered version usually settles once the product is gone and does not come back off treatment. Confuse the two and a person can spend years on immunosuppression for an injury a capsule caused and stopping the capsule would have resolved. Telling them apart takes a careful history, the right labs in the right order, and a physician who thinks to ask what is in your cabinet. This is not something you sort out by reading, and it is not something a fifteen-minute urgent care visit is built to catch. If your liver enzymes are up and nobody has taken a full supplement history, that is the appointment to make.

What to watch for

Yellowing of the eyes or skin, or urine turning dark like tea or cola.
Itching all over without a rash, which is the ashwagandha and bile-flow pattern.
Nausea, loss of appetite, unusual fatigue, or an ache under the right ribs, one to four months after starting something new.
Nothing at all. A meaningful share of these are found on routine labs in someone who feels fine, which is the whole argument for drawing labs on people who take supplements.

If any of the first three are happening, stop the product and get liver labs promptly. Do not restart it later to see whether it was really the cause. Rechallenge reproduces the injury faster and harder, and that is not a test worth running on yourself.

The good news, and the reason for urgency

Stopping the supplement is the treatment, and the large majority of people recover. In one turmeric series about ninety percent had liver enzymes at least halfway back within a month of stopping. Ashwagandha cases normalize as well, though more slowly, over one to nine months. Steroids get used in a minority with severe or autoimmune-looking disease, but stopping the product alone was enough for most, and the right role for steroids here is still unsettled.

The urgency is this. Supplement-related liver failure has worse transplant-free survival than liver failure from prescription drugs, and the leading explanation is delay. People do not connect a natural product to their symptoms, and clinicians do not always ask. Patients frequently do not mention supplements at all, because in their mind a supplement is not a medication. It is. Anything that can put you in a transplant conversation is a medication.

The over-the-counter shelf, while we are here

Acetaminophen is still the single biggest cause of drug-induced liver injury and acute liver failure in this country, roughly half of all cases. Unlike the botanicals above, that one is dose-dependent and predictable: safe at label doses, dangerous above them, and more dangerous if you are fasting or drinking. Most of the accidental cases come from stacking products, a cold medicine plus a pain reliever plus a sleep aid, all of them containing it. Read the labels and add them up. The over-the-counter anti-inflammatories, ibuprofen and naproxen, cause unpredictable idiosyncratic injury far less often, but they are on the list. That side of the aisle now has its own page: does Tylenol damage your liver, including what to do if you think you have taken too much.

Measure, don’t guess

None of this means stop taking botanicals. It means stop buying them blind. What I do in the office is straightforward. I take a full supplement inventory, brands and formulations included, because that is the history nobody takes. We check liver enzymes and bilirubin before starting anything with a known hepatic signal, and again once you have been on it, so a problem shows up as a number on a page instead of jaundice in the mirror. If you already have liver disease, or you are on other medications that tax the liver, that changes what I will and will not use. And what I recommend comes through our office, sourced and individualized after labs, rather than chosen off a shelf on the strength of a label claim.

Liver enzymes that are already drifting up deserve a real workup rather than another supplement, and my page on fatty liver disease covers the most common reason they drift. If you want the broader picture on which supplements have evidence behind them and which do not, my pages on collagen supplements and food as medicine take the same approach: what the trials actually show, including when the answer is disappointing. And because people ask what kind of physician says all this out loud, here is what a naturopathic medical doctor can prescribe in Arizona.

Text us at 480-219-2624 to schedule, or call. Quick response, real scheduling, no phone tree.

To Health and Wellness,
Dr. Ty Tallman

This page is educational and is not a substitute for individualized medical advice, diagnosis, or treatment. · Leer en español

References

Hepatology, 2023 — AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury.
Hepatology, 2017 — liver injury from herbal and dietary supplements.
The New England Journal of Medicine, 2019 — drug-induced liver injury, types and phenotypes.
Clinical Gastroenterology and Hepatology, 2023 — the evolving profile of idiosyncratic drug-induced liver injury.
Gastroenterology, 2015 — herbal products and the liver, adverse effects and mechanisms.
Hepatology, 2021 — HLA-B*35:01 and green tea-induced liver injury.
EFSA Journal, 2018 — scientific opinion on the safety of green tea catechins.
The American Journal of Medicine, 2023 — liver injury associated with turmeric, ten cases from the Drug-Induced Liver Injury Network.
Histopathology, 2025 — turmeric supplement-associated hepatitis, clinicopathological series.
Pharmaceutical Biology, 2026 — hepatotoxicity associated with turmeric- and curcuminoid-containing supplements, USP review.
British Journal of Clinical Pharmacology, 2021 — acute liver injury following turmeric use, Italian phytovigilance analysis and systematic review.
Hepatology Communications, 2023 — ashwagandha-induced liver injury, case series and literature review.
Pharmaceuticals, 2023 — herb-induced liver injury by Ayurvedic ashwagandha assessed by updated RUCAM.
International Journal of Environmental Research and Public Health, 2023 — ashwagandha-induced liver injury, case report.
Phytotherapy Research, 2026 — potential adverse effects of ashwagandha, critical review of preclinical and clinical evidence.
Nutrition & Metabolism, 2025 — Withania somnifera supplementation, mechanisms, benefits, and safety review.
Liver International, 2025 — challenges in herbal-induced liver injury identification and prevention.
Journal of Hepatology, 2023 — nomenclature, diagnosis, and management of drug-induced autoimmune-like hepatitis.
The Medical Journal of Australia, 2021 — drug-induced liver injury in Australia, the increasing proportion linked with herbal and dietary supplements.
The American Journal of Gastroenterology, 2021 — ACG clinical guideline, idiosyncratic drug-induced liver injury.
The American Journal of Gastroenterology, 2023 — acute liver failure guidelines.
Gastroenterology, 2026 — evaluation of abnormal liver biochemical test results.
Alimentary Pharmacology & Therapeutics, 2013 — herbal and dietary supplement hepatotoxicity, review.
Journal of Internal Medicine, 2026 — an update on drug-induced liver injury.